SG Americas Securities LLC Boosts Holdings in Alignment Healthcare, Inc. $ALHC

SG Americas Securities LLC lifted its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 148.5% during the 4th quarter, HoldingsChannel reports. The fund owned 60,390 shares of the company’s stock after acquiring an additional 36,084 shares during the period. SG Americas Securities LLC’s holdings in Alignment Healthcare were worth $1,193,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Assenagon Asset Management S.A. boosted its position in shares of Alignment Healthcare by 6,708.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,774,975 shares of the company’s stock worth $35,056,000 after acquiring an additional 1,748,903 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Alignment Healthcare by 17.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 19,438 shares of the company’s stock worth $414,000 after acquiring an additional 2,909 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Alignment Healthcare by 83.8% in the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after acquiring an additional 987 shares during the last quarter. Mirabella Financial Services LLP acquired a new stake in shares of Alignment Healthcare in the third quarter worth approximately $186,000. Finally, Hudson Bay Capital Management LP acquired a new stake in shares of Alignment Healthcare in the third quarter worth approximately $4,581,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. KeyCorp reissued an “overweight” rating and issued a $28.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 22nd. TD Cowen raised their target price on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research report on Friday, January 16th. UBS Group raised their target price on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 14th. Finally, Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, March 7th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.75.

Alignment Healthcare Stock Performance

NASDAQ ALHC opened at $21.66 on Wednesday. The firm has a market capitalization of $4.43 billion, a P/E ratio of -2,163.84, a P/E/G ratio of 2.74 and a beta of 1.20. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71. The business’s 50-day simple moving average is $19.37 and its 200-day simple moving average is $18.96.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.10. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The company’s revenue was up 44.4% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.16) EPS. Equities analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Activity

In other news, CEO John E. Kao sold 180,000 shares of Alignment Healthcare stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $21.11, for a total value of $3,799,800.00. Following the transaction, the chief executive officer directly owned 2,832,641 shares of the company’s stock, valued at $59,797,051.51. The trade was a 5.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, President Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total value of $655,602.16. Following the completion of the transaction, the president directly owned 1,058,813 shares in the company, valued at $18,889,223.92. This represents a 3.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,094,997 shares of company stock worth $20,879,431 over the last ninety days. Corporate insiders own 7.00% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.